间皮瘤复杂染色体易位的潜在新抗原表达
研究探讨恶性胸膜间皮瘤在低肿瘤突变负荷下如何产生新抗原,采用配对末端测序、RNA测序及T细胞受体测序结合计算机预测与免疫学试验,发现染色体结构重排相关连接转录可预测产生多种新抗原,部分能结合患者特异性MHC并扩增瘤内T细胞克隆。
要点
- 间皮瘤中染色体间或染色体内重排普遍存在,常表现为染色体碎裂或染色体丛集等模式。
- 重排相关连接转录可预测产生多种新抗原,部分可结合患者特异性MHC并扩增瘤内T细胞克隆。
- 对预测新抗原响应的T细胞也存在于患者循环T细胞库中。
核心结论
- 研究发现染色体结构重排可驱动潜在新抗原表达,可能为间皮瘤免疫治疗策略开发及患者选择提供依据。
研究设计与样本
- 研究采用配对末端测序(n=22)、RNA测序(n=28)及T细胞受体测序,结合计算机预测与免疫学试验。
- 另分析癌症基因组图谱间皮瘤队列的基因组芯片数据。
主要发现
- 每个标本均存在染色体间或染色体内重排,常呈染色体碎裂或染色体丛集模式。
- 重排相关连接转录预测可产生多种潜在新抗原,部分被证明可结合患者特异性MHC分子并扩增瘤内T细胞克隆。
- 对预测新抗原响应的T细胞也存在于患者循环T细胞库中。
- 癌症基因组图谱间皮瘤队列基因组芯片数据分析提示,多个染色体碎裂样事件对生存有负面影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Malignant pleural mesothelioma is a disease primarily associated with exposure to the carcinogen asbestos. Whereas other carcinogen-related tumors are associated with a high tumor mutation burden, mesothelioma is not. We sought to resolve this discrepancy. METHODS: We used mate-pair (n = 22), RNA (n = 28), and T cell receptor sequencing along with in silico predictions and immunologic assays to understand how structural variants of chromosomes affect the transcriptome. RESULTS: We observed that inter- or intrachromosomal rearrangements were present in every specimen and were frequently in a pattern of chromoanagenesis such as chromoplexy or chromothripsis. Transcription of rearrangement-related junctions was predicted to result in many potential neoantigens, some of which were proven to bind patient-specific major histocompatibility complex molecules and to expand intratumoral T cell clones. T cells responsive to these predicted neoantigens were also present in a patient's circulating T cell repertoire. Analysis of genomic array data from the mesothelioma cohort in The Cancer Genome Atlas suggested that multiple chromothriptic-like events negatively impact survival. CONCLUSIONS: Our findings represent the discovery of potential neoantigen expression driven by structural chromosomal rearrangements. These results may have implications for the development of novel immunotherapeutic strategies and the selection of patients to receive immunotherapies.
引用
- Mansfield AS, Peikert T, Smadbeck JB, et al. Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma. J Thorac Oncol. 2018. PMID: 30316012. doi:10.1016/j.jtho.2018.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。